A succinct synthesis of valganciclovir hydrochloride – A cytomegalovirus (CMV) retinitis inhibitor

A succinct synthesis of valganciclovir hydrochloride – A cytomegalovirus (CMV) retinitis inhibitor

Bibliographic Details
Main Author:	Karrothu Srihari Babu
Format:	Article
Language:	English
Published:	Arkat USA, Inc. 2011-01-01
Series:	ARKIVOC
Online Access:	https://www.arkat-usa.org/arkivoc-journal/browse-arkivoc/ark.5550190.0012.215

Similar Items

Oral Valganciclovir as a Preemptive Treatment for Cytomegalovirus (CMV) Infection in CMV-Seropositive Liver Transplant Recipients.
by: Jong Man Kim, et al.
Published: (2015-01-01)

Valganciclovir in the treatment of cytomegalovirus retinitis in HIV-infected patients
by: A Jayaprakash Patil, et al.
Published: (2010-03-01)

Cytomegalovirus retinitis treated with valganciclovir in Wegener&rsquo;s granulomatosis
by: Kabata Y, et al.
Published: (2012-03-01)

Challenges in Cytomegalovirus (CMV) Retinitis Management
by: Denisa Rosati, et al.
Published: (2019-09-01)

Recombinant luciferase-expressing human cytomegalovirus (CMV) for evaluation of CMV inhibitors
by: Posner Gary H, et al.
Published: (2011-01-01)

Comparison between valganciclovir and aciclovir/valaciclovir for CMV prophylaxis in pediatric renal transplantation
by: M Fila, et al.
Published: (2015-01-01)

Treatment of unilateral zone I cytomegalovirus retinitis in acute lymphoblastic leukemia with oral valganciclovir and intravitreal ganciclovir
by: Koushik Tripathy, et al.
Published: (2017-01-01)

Onset of valganciclovir resistance in two infants with congenital cytomegalovirus infection
by: Francesca Garofoli, et al.
Published: (2020-09-01)

Valganciclovir for the prophylaxis and treatment of cytomegalovirus infection in solid organ transplantation
by: Erin Wade Ticehurst, et al.
Published: (2010-03-01)

Efficacy of Low Dose Valganciclovir Prophylaxis for Cytomegalovirus Infection in Kidney Transplantation
by: Ümit Özçelik, et al.
Published: (2020-01-01)

Effects of oral valganciclovir prophylaxis for cytomegalovirus infection in heart transplant patients
by: Doesch AO, et al.
Published: (2012-10-01)

Letermovir for Cytomegalovirus Prophylaxis in Lung Transplant Patients with Valganciclovir-Induced Leukopenia
by: Arindam Singha, et al.
Published: (2021-04-01)

Refractory ulcerative colitis complicated by cytomegalovirus infection successfully treated with valganciclovir
by: Tiziana Larussa, et al.
Published: (2012-11-01)

Role of oral valganciclovir in sick preterm with cytomegalovirus virus infection and ventilation dependence
by: Anumodan Gupta, et al.
Published: (2019-01-01)

Assessment of mitochondrial toxicity in newborns and infants with congenital cytomegalovirus infection treated with valganciclovir
by: Cantó-Santos, J., et al.
Published: (2022)

Efficacy of valganciclovir and ganciclovir for cytomegalovirus disease in solid organ transplants: A meta-analysis
by: Siavash Vaziri, et al.
Published: (2014-01-01)

Unexpected hearing improvement after treatment with valganciclovir in a child with congenital cytomegalovirus infection
by: Silvia Palma, et al.
Published: (2021-04-01)

Dataset of aqueous humor cytokine profile in HIV patients with Cytomegalovirus (CMV) retinitis
by: Jayant Venkatramani Iyer, et al.
Published: (2016-09-01)

Cytomegalovirus (CMV) Infection and Latency
by: Christine M. O’Connor
Published: (2021-03-01)

Valganciclovir for cytomegalovirus preemptive therapy in patients following allogeneic hematopoietic stem cell transplantation
by: LU Xuan, et al.
Published: (2020-09-01)

Succinct Indexes
by: He, Meng
Published: (2008)

Succinct Indexes
by: He, Meng
Published: (2008)

Valganciclovir for cytomegalovirus prevention in solid organ transplant patients: an evidence-based reassessment of safety and efficacy.
by: Andre C Kalil, et al.
Published: (2009-01-01)

Efficacy of Valganciclovir Treatment Depends on the Severity of Hearing Dysfunction in Symptomatic Infants with Congenital Cytomegalovirus Infection
by: Shohei Ohyama, et al.
Published: (2019-03-01)

Long-term results of oral valganciclovir for treatment of anterior segment inflammation secondary to cytomegalovirus infection
by: Wong VW, et al.
Published: (2012-04-01)

Retinite por citomegalovirus (CMV) após terapia imunossupressora para vasculite leucocitoclástica Cytomegalovirus (CMV) retinitis after immunossupressive therapy for leukocytoclastic vasculitis
by: Carlos Ewerton Maia Rodrigues, et al.
Published: (2009-02-01)

Succinct Data Structures
by: Gupta, Ankur
Published: (2007)

Cytomegalovirus (CMV) seroprevalence in the adult population of Germany.
by: Raskit Lachmann, et al.
Published: (2018-01-01)

Factors associated with cytomegalovirus (CMV) infection in neonates
by: Diar, Hitesh Amrat
Published: (2014)

Treating HIV-associated cytomegalovirus retinitis with oral valganciclovir and intra-ocular ganciclovir by primary HIV clinicians in southern Myanmar: a retrospective analysis of routinely collected data
by: Jillian Murray, et al.
Published: (2020-11-01)

Cytomegalovirus (CMV) Pneumonitis: Cell Tropism, Inflammation, and Immunity
by: Luís Fonseca Brito, et al.
Published: (2019-08-01)

Succinct non-Interactive arguments
by: Chiesa, Alessandro
Published: (2015)

Finding Succinct Representations For Clusters
by: Gupta, Aparna
Published: (2019)

Human cytomegalovirus (CMV) in Africa: a neglected but important pathogen
by: Matthew Bates, et al.
Published: (2016-07-01)

AbsSynthe: abstract synthesis from succinct safety specifications
by: Romain Brenguier, et al.
Published: (2014-07-01)

Cytomegalovirus (CMV) immune monitoring with ELISPOT and QuantiFERON-CMV assay in seropositive kidney transplant recipients.
by: Hyeyoung Lee, et al.
Published: (2017-01-01)

Cytomegalovirus prophylaxis using low-dose valganciclovir in patients with acute leukemia undergoing allogeneic hematopoietic stem-cell transplantation
by: Po-Hsien Li, et al.
Published: (2021-03-01)

Treatment of cytomegalovirus anterior segment infection with intravitreal injection of ganciclovir in adjunction with or without oral valganciclovir: a long-term results
by: Yu-Chun Cheng, et al.
Published: (2021-02-01)

Effectiveness of Valganciclovir 900mg Versus 450mg for Cytomegalovirus Prophylaxis in Renal Transplantation: A Systematic Review and Meta-Analysis
by: wang xin, et al.
Published: (2017-07-01)

Highly quantitative serological detection of anti-cytomegalovirus (CMV) antibodies
by: Alter Harvey J, et al.
Published: (2009-05-01)